Notices. Notice of registration
332 words·~2 min read·
/register/2015/09/30/2015-24747A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Manufacturer of Controlled Substances Registration: Noramco, Inc. ACTION: Notice of registration. SUMMARY: Noramco, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration
(DEA)grants Noramco, Inc. registration as a manufacturer of those controlled substances. SUPPLEMENTARY INFORMATION: By notice dated April 14, 2015, and published in the **Federal Register** on April 22, 2015, 80 FR 22555, Noramco, Inc., 500 Swedes Landing Road, Wilmington, Delaware 19801-4417 applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted for this notice. The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Noramco, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the basic classes of controlled substances: Controlled substance Schedule Codeine-N-oxide
(9053)I Dihydromorphine
(9145)I Morphine-N-oxide
(9307)I Amphetamine
(1100)II Methylphenidate
(1724)II Phenylacetone
(8501)II Codeine
(9050)II Dihydrocodeine
(9120)II Oxycodone
(9143)II Hydromorphone
(9150)II Hydrocodone
(9193)II Morphine
(9300)II Oripavine
(9330)II Thebaine
(9333)II Opium extracts
(9610)II Opium fluid extract
(9620)II Opium tincture
(9630)II Opium, powdered
(9639)II Opium, granulated
(9640)II Oxymorphone
(9652)II Noroxymorphone
(9668)II Tapentadol
(9780)II The company plans to manufacture the above-listed controlled substances in bulk for distribution to its customers. Dated: September 21, 2015. Joseph T. Rannazzisi, Deputy Assistant Administrator. [FR Doc. 2015-24747 Filed 9-29-15; 8:45 am]
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources